These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 27813531)

  • 1. Overexpression of Mcl-1 exacerbates lymphocyte accumulation and autoimmune kidney disease in lpr mice.
    Anstee NS; Vandenberg CJ; Campbell KJ; Hughes PD; O'Reilly LA; Cory S
    Cell Death Differ; 2017 Mar; 24(3):397-408. PubMed ID: 27813531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe impairment of B cell function in lpr/lpr mice expressing transgenic Fas selectively on B cells.
    Komano H; Ikegami Y; Yokoyama M; Suzuki R; Yonehara S; Yamasaki Y; Shinohara N
    Int Immunol; 1999 Jul; 11(7):1035-42. PubMed ID: 10383935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.
    Choi Y; Ramnath VR; Eaton AS; Chen A; Simon-Stoos KL; Kleiner DE; Erikson J; Puck JM
    Clin Immunol; 1999 Oct; 93(1):34-45. PubMed ID: 10497009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphoid cell accumulation in salivary glands of autoimmune MRL mice can be due to impaired apoptosis.
    Skarstein K; Nerland AH; Eidsheim M; Mountz JD; Jonsson R
    Scand J Immunol; 1997 Oct; 46(4):373-8. PubMed ID: 9350288
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Nagasu A; Mukai T; Iseki M; Kawahara K; Tsuji S; Nagasu H; Ueki Y; Ishihara K; Kashihara N; Morita Y
    Cells; 2019 Apr; 8(5):. PubMed ID: 31052273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acceleration of lpr lymphoproliferative and autoimmune disease by transgenic protein kinase CK2 alpha.
    Rifkin IR; Channavajhala PL; Kiefer HL; Carmack AJ; Landesman-Bollag E; Beaudette BC; Jersky B; Salant DJ; Ju ST; Marshak-Rothstein A; Seldin DC
    J Immunol; 1998 Nov; 161(10):5164-70. PubMed ID: 9820486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic expression of Fas in T cells blocks lymphoproliferation but not autoimmune disease in MRL-lpr mice.
    Fukuyama H; Adachi M; Suematsu S; Miwa K; Suda T; Yoshida N; Nagata S
    J Immunol; 1998 Apr; 160(8):3805-11. PubMed ID: 9558084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In CD8+ T cell-deficient lpr/lpr mice, CD4+B220+ and CD4+B220- T cells replace B220+ double-negative T cells as the predominant populations in enlarged lymph nodes.
    Giese T; Davidson WF
    J Immunol; 1995 May; 154(10):4986-95. PubMed ID: 7537297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The absence of CD44 ameliorates Fas(lpr/lpr) disease.
    Weber GF
    Autoimmunity; 2004 Feb; 37(1):1-8. PubMed ID: 15115305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice.
    Schwarting A; Wada T; Kinoshita K; Tesch G; Kelley VR
    J Immunol; 1998 Jul; 161(1):494-503. PubMed ID: 9647261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoreactive MZ and B-1 B-cell activation by Faslpr is coincident with an increased frequency of apoptotic lymphocytes and a defect in macrophage clearance.
    Qian Y; Conway KL; Lu X; Seitz HM; Matsushima GK; Clarke SH
    Blood; 2006 Aug; 108(3):974-82. PubMed ID: 16861350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of P2X7 receptor plasma membrane expression and function in pathogenic B220+ double-negative T lymphocytes of autoimmune MRL/lpr mice.
    Le Gall SM; Legrand J; Benbijja M; Safya H; Benihoud K; Kanellopoulos JM; Bobé P
    PLoS One; 2012; 7(12):e52161. PubMed ID: 23284917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRL/lpr CD4- CD8- and CD8+ T cells, respectively, mediate Fas-dependent and perforin cytotoxic pathways.
    Benihoud K; Bonardelle D; Bobé P; Kiger N
    Eur J Immunol; 1997 Feb; 27(2):415-20. PubMed ID: 9045912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci.
    Watson ML; Rao JK; Gilkeson GS; Ruiz P; Eicher EM; Pisetsky DS; Matsuzawa A; Rochelle JM; Seldin MF
    J Exp Med; 1992 Dec; 176(6):1645-56. PubMed ID: 1460423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stabilized
    Xu X; Huang J; Zhao M; Chen H; Mo J; Zhou X; Su Q; Yu B; Huang Z
    J Immunol Res; 2017; 2017():3469108. PubMed ID: 29250557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined deficiency of proapoptotic regulators Bim and Fas results in the early onset of systemic autoimmunity.
    Hutcheson J; Scatizzi JC; Siddiqui AM; Haines GK; Wu T; Li QZ; Davis LS; Mohan C; Perlman H
    Immunity; 2008 Feb; 28(2):206-17. PubMed ID: 18275831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of RANTES in the development of autoimmune tissue injuries in MRL-Fas lpr mice.
    Tsukahara T; Makino Y; Fujii T; Ogawa M; Saisho H; Hamano Y; Ueda S; Akikusa B; Danoff TM
    Clin Immunol; 2002 Apr; 103(1):89-97. PubMed ID: 11987989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Origin of CD4-CD8-B220+ T cells in MRL-lpr/lpr mice. Clues from a T cell receptor beta transgenic mouse.
    Zhou T; Bluethmann H; Eldridge J; Berry K; Mountz JD
    J Immunol; 1993 Apr; 150(8 Pt 1):3651-67. PubMed ID: 7682246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requirement of Fas expression in B cells for tolerance induction.
    Fukuyama H; Adachi M; Suematsu S; Miwa K; Suda T; Yoshida N; Nagata S
    Eur J Immunol; 2002 Jan; 32(1):223-30. PubMed ID: 11782013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD95 and the MRL-lpr Mouse Model.
    Flynn RJ
    Methods Mol Biol; 2017; 1557():219-228. PubMed ID: 28078597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.